MUNICH — July 26, 2022 — Insempra, a biology-based company that enables companies to manufacture premium products in partnership with nature, today announces a strategic investment in Solena Materials Ltd., a synthetic biology company. Solena, a spin-out from Imperial College London, is developing synthetic proteins for high-performance clothing fibers.
The investment will enable Insempra, formerly Origin.Bio, to accelerate its strategy of harnessing new technologies to advance organic production processes, creating naturally superior products to drive the regenerative revolution. Solena will be a major part of Insempra’s platform to deliver high performing, inherently sustainable ingredients for a wide range of industries.
Solena uses computer design to develop new classes of synthetic proteins to produce high performance clothing fibers capable of absorbing large amounts of kinetic energy. Insempra will accelerate the development and production of these synthetic proteins on an industrial scale, offering better bio-based solutions to petrochemical-based and non-biodegradable materials or fibers extracted from nature or animals, such as silk, currently used in textile and clothing industries. . This technology also reduces other environmental impacts such as the increase of microplastics in water bodies from the washing of textiles of petrochemical origin.
Jens Klein, Founder and CEO of Insempra and CEO of Solena Materials, said, “We are extremely excited about this investment in Solena, which will help accelerate our market-driven approach to developing premium, inherently sustainable ingredients. We look forward to accelerating Solena’s development and production of their unique synthetic proteins to develop custom high performance fibers for a variety of applications.
Dr. James MacDonald, Inventor, Co-Founder and CTO of Solena Materials, added: “The team and I are excited to make this technology a huge success.
Professor Paul Freemont of Imperial College London added: “This investment from Insempra recognizes the potential of our technology to revolutionize high performance fabrics and their supply chains. Together, we can harness our synthetic biology capabilities to develop, produce and manufacture a new class of superior, more sustainable fiber technologies.
Insempra, co-founder of Solena, will be the sole contributing shareholder of Solena, which is based at Imperial College’s Translation & Innovation Hub (I-HUB) in White City, London. Solena’s board will consist of Dr James MacDonald from Solena, Professor Paul Freemont and Professor Milo Shaffer from Imperial College London, and Jens Klein and Andreas Heyl from Insempra.
Posted: July 27, 2022